Nasdaq Stockholm AB has assessed that Meds Apotek AB, company registration number 559093-4575, fulfills Nasdaq First North Premier Growth Market's listing requirements.
Provided that Meds Apotek AB, applies for admission to trading of its shares on Nasdaq First North Premier Growth Market Sweden, first day of trading is expected to be September 23, 2025.
The company has 17,251,424 shares as per today's date.
Shares
| Short name: | MEDS |
| Maximum Number of shares to be listed: | 19,194,819 |
| ISIN code: | SE0018014110 |
| Round Lot: | 1 |
| Order book ID: | 266142 |
| Company Registration Number: | 559093-4575 |
| Market segment: | First North STO/8 |
| Tick Size table: | MiFID II tick size table |
| MIC code: | SSME |
| Trading currency: | SEK |
Classification
| Code | Name |
| 20 | Health Care |
| 20103015 | Pharmaceuticals |
When issued trading
Trading will be on a when issued basis from September 23 up and including September 24, 2025, i.e. trading will begin before all conditions in the offering have been fulfilled and will cease if the offering is not completed. For further information see page 25 and page 80 in the prospectus.
This information is distributed at the request of the Certified Adviser, FNCA Sweden AB. For further information, please call FNCA Sweden AB on 0707995812.
